Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Healthcare Market Research Reports

Titlepublishedprice

Italy Pharmaceuticals and Healthcare Report Q3 2016

By Business Monitor International
"...... ing any additional fiscal capacity to ease the tax burden instead of ramping up spending. This will continue to negatively impact the healthcare sector and particularly pharmaceutical spending, a large beneficiary of public funds. H......"
04-May-2016$1295

India Pharmaceuticals and Healthcare Report Q3 2016

By Business Monitor International
"...... submission, such as low levels of intellectual property and challenges in market access. As a result of these factors, innovative firms will adopt a cautious approach to India, which remains attractive due to its large medicine mark......"
04-May-2016$1295

Finland Pharmaceuticals and Healthcare Report Q3 2016

By Business Monitor International
"...... d healthcare sectors primary targets for this, as both are large beneficiaries of public funds. However, Finland will still continue to be one the wealthiest countries in the world in terms of real GDP per capita, and this will - along wi......"
04-May-2016$1295

Cuba Pharmaceuticals and Healthcare Report Q3 2016

By Business Monitor International
"...... ty will be further developed as the country's global reach and integration strengthens. Meanwhile, we highlight an expected rapid growth in the healthcare tourism industry in Cuba in the next years. However, we expect progress to be......"
04-May-2016$1295

Cote d`Ivoire Pharmaceuticals and Healthcare Report Q3 2016

By Business Monitor International
"...... coming years, in line with the rising non-communicable disease burden. However, these will be limited in their success as the West African nation continues to lack effective patent legislation and a reimbursement regime. Investor sentime......"
04-May-2016$1295

Costa Rica Pharmaceuticals and Healthcare Report Q3 2016

By Business Monitor International
"...... ment into the public healthcare service system's operational efficiency will increase Costa Rica's attractiveness for foreign investment over the long term. Headline Expenditure Projections Pharmaceuticals: CRC446.94bn (USD830......"
04-May-2016$1295

China Pharmaceuticals and Healthcare Report Q3 2016

By Business Monitor International
"...... g healthcare costs. Long and uncertain drug approval times will also remain a factor impinging on sales growth, as time is needed for authorities to fully develop and implement regulatory reforms. Headline Expenditure Projections......"
04-May-2016$1295

Bulgaria Pharmaceuticals and Healthcare Report Q3 2016

By Business Monitor International
"...... ce, but new legislation appears to be addressing the long-held issue of an over-reliance on private spending. Cost-containment will affect revenue-generating opportunities for drugmakers, but generic medicines will gain market share......."
04-May-2016$1295

Brazil Pharmaceuticals and Healthcare Report Q3 2016

By Business Monitor International
"...... azil's private healthcare market will experience contraction in real terms in 2016 due to the deteriorating political and economic outlook. Headline Expenditure Projections Pharmaceuticals: BRL66.8bn (USD20.0bn) in 2015 to BRL......"
04-May-2016$1295

Botswana Pharmaceuticals and Healthcare Report Q3 2016

By Business Monitor International
"...... g HIV/AIDS burden in the country will, however, continue to provide opportunities for generic drugmakers in the public healthcare sector. As the burden of non-communicable diseases increases in the country, we expect this to provide......"
04-May-2016$1295